Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP‐1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|75|6|616-627

ISSN： 0270-4137

Source： THE PROSTATE, Vol.75, Iss.6, 2015-05, pp. : 616-627

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Absence of Immunoreactivity for Tissue Inhibitor of Metalloproteinase-1 (TIMP-1), but Not for TIMP-2, Protein Is Associated with a Favorable Prognosis in Aggressive Breast Carcinoma

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 196-203

Karger

Access to resources Recommend Favorite

Diethylstilboestrol (1 mg) in the Management of Castration-Resistant Prostate Cancer

By  

Urologia Internationalis, Vol. 94, Iss. 3, 2014-10 ,pp. : 307-312

Karger

Access to resources Recommend Favorite

Tissue inhibitor of metalloproteinase-1 levels in plasma from tumour arteries and veins of patients with rectal cancer

By Frederiksen C.   Lykke J.   Christensen Ib J.   Brünner N.   Nielsen H. J.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 67, Iss. 5, 2007-01 ,pp. : 545-552

Informa Healthcare

Access to resources Recommend Favorite

Adipocytes affect castration‐resistant prostate cancer cells to develop the resistance to cytotoxic action of NK cells with alterations of PD‐L1/NKG2D ligand levels in tumor cells

By  

THE PROSTATE, Vol. 78, Iss. 5, 2018-04 ,pp. : 353-364

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of S-1 in Patients with Castration-Resistant Prostate Cancer: A Phase II Study

By  

Oncology, Vol. 78, Iss. 5-6, 2010-08 ,pp. : 323-328

Karger

Access to resources Recommend Favorite